Application Information

Application Number : 2025/001666

Application Date : 28-07-2017

Application Type : EPC Fasikül

Grant Number : 2025-GE-95291

Grant Date : 13-02-2025

Registration Number : 2025 001666

Registration Date : 2025-02-21

Protection Type : Patent

European Patent Publication Number (B1) : EP3490560B1

European Patent Application Number : EP17754226.3

Applicants

Person No	Name	Address
7823165	JANSSEN PHARMACEUTICA, N.V.	TURNHOUTSEWEG 30 2340 BEERSE BELÇİKA

Inventors

Person No	Name	Address
7823161	Marco GOTTARDIS	9 HARRIS ROAD PRINCETON NEW JERSEY 08540 A.B.D.
7823164	Douglas H YAMADA	1400 MCKEAN ROAD SPRING HOUSE PENNSYLVANIA 19477 A.B.D.
7823163	Linda SNYDER	1400 MCKEAN ROAD SPRING HOUSE PENNSYLVANIA 19477 A.B.D.
7823162	Rebecca HAWKINS	1400 MCKEAN ROAD SPRING HOUSE 19477 PANAMA CUMHURİYETİ

Invention Information

Name Of Invention	PROSTAT KANSERİNİN TEDAVİ EDİLMESİNE YÖNELİK BİR USULDE KULLANIMA YÖNELİK NİRAPARİB
Summary Of Invention	Niraparib'in buna ihtiyacı olan bir deneğe uygulanması yoluyla prostat kanserinin tedavi edilmesine yönelik usuller açıklanır.

Attorney Information

Name	TOLGA ÇAYLAK DIŞ PATENT MARKA TESCİL ve DANIŞMANLIK HİZ. LTD. ŞTİ.
Address	GİRNE MAH. ELİFLİ SOK. NO:27 BAY PLAZA KAT:5-6-7 MALTEPE/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
29-07-2016	US 201662368466P	US
01-08-2016	US 201662369239P	US

Classes of The Invention

IPC
A61K31/454
A61P35/00

Patent Application Procedures

Date	Date of Notification	Operation	Document
	14-02-2025	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
12-02-2025		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
21-02-2025	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)